Drug recall D-0592-2024
Product
Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-5; Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534,
Reason for recall
Cross contamination with other products.
Lots and codes
Lot# (a) Lots L300255, L300262, Exp Date 07/31/2025; (b)L300263, Exp Date 08/31/2025
Recall details
- Recalling firm
- Zydus Pharmaceuticals (USA) Inc, Pennington, NJ
- Quantity
- 170,755 vials
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 2, 2024
Related products
- Verapamil Hydrochloride – drug information
- NDC 70710-1644 Verapamil Hydrochloride · Verapamil Hydrochloride 2.5 mg/mL · Zydus Pharmaceuticals USA Inc.
- NDC 70710-1643 Verapamil Hydrochloride · Verapamil Hydrochloride 2.5 mg/mL · Zydus Pharmaceuticals USA Inc.